Paul studied Natural Sciences at the University of Cambridge, and stayed on at Cambridge to complete a PhD in the Department of Genetics. He carried out post-doctoral research in developmental neurobiology and neuroscience at King's College London and the University of Oxford, and spent two years in the biotech industry. Paul found science communication to be the most rewarding aspect of these roles, and enjoys explaining complex concepts clearly and compellingly.
Since moving into medical communications, Paul has gained substantial experience in health economics and outcomes research, and has developed health technology assessment submissions and global value dossiers as well as traditional medical communications. Paul has worked in a range of disease areas; he has particular expertise in oncology, ophthalmology and neurology but always enjoys learning about new therapy areas!
Defining innovation with respect to new medicines: a systematic review from a payer perspective
de Solà-Morales O, Cunningham D, Flume M, Overton PM, Shalet N, Capri S.
Defining and measuring the affordability of new medicines: a systematic review.
Antoñanzas F, Terkola R, Overton PM, Shalet N, Postma M.
The Drosophila HMG-domain proteins SoxNeuro and Dichaete direct trichome formation via the activation of shavenbaby and the restriction of Wingless pathway activity.
Overton PM, Chia W, Buescher M.
Asymmetric localisation of Miranda and its cargo proteins during neuroblast division requires the anaphase-promoting complex/cyclosome.
Slack C, Overton PM, Tuxworth RI, Chia W.
A mosaic genetic screen for novel mutations affecting Drosophila neuroblast divisions.
Slack C, Somers WG, Sousa-Nunes R, Chia W, Overton PM.
Evidence for differential and redundant function of the Sox genes Dichaete and SoxN during CNS development in Drosophila.
Overton PM, Meadows LA, Urban J, Russell S.